Literature DB >> 533266

Evaluation of gentamicin and penicillin as a synergistic combination in experimental murine listeriosis.

C E Edmiston, R C Gordon.   

Abstract

The administration of a combination of penicillin and gentamicin to mice given an intraperitoneal challenge of a highly pathogenic strain of Listeria monocytogenes resulted in increased survival as compared with groups receiving penicillin alone or gentamicin alone or a control group that received no antibiotic. The median survival of animals that eventually died was no longer than in groups receiving single antibiotics and suggests that additional studies should be carried out to further investigate the possibility of synergism in animal models.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 533266      PMCID: PMC352967          DOI: 10.1128/AAC.16.6.862

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  3 in total

1.  Listerial prosthetic valve endocarditis. Successful medical therapy.

Authors:  L D Saravolatz; K H Burch; T Madhavan; E L Quinn
Journal:  JAMA       Date:  1978-11-10       Impact factor: 56.272

2.  Synergism of penicillin and gentamicin against Listeria monocytogenes in ex vivo hemodialysis culture.

Authors:  K Mohan; R C Gordon; T C Beaman; R C Belding; D Luecke; C Edmiston; P Gerhardt
Journal:  J Infect Dis       Date:  1977-01       Impact factor: 5.226

3.  Influence of several antibiotics, singly and in combination, on the growth of Listeria monocytogenes.

Authors:  R C Gordon; F F Barrett; D J Clark
Journal:  J Pediatr       Date:  1972-04       Impact factor: 4.406

  3 in total
  10 in total

Review 1.  Use of aminoglycosides in treatment of infections due to intracellular bacteria.

Authors:  M Maurin; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

Review 2.  Listeria Monocytogenes infections.

Authors:  R C Gordon
Journal:  Indian J Pediatr       Date:  1995 Jan-Feb       Impact factor: 1.967

Review 3.  Management of listeriosis.

Authors:  H Hof; T Nichterlein; M Kretschmar
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Solitary supratentorial Listeria monocytogenes brain abscess in an immunocompromised patient.

Authors:  James A West; Anthony R Onofrio; Lauren C Martinez; Michael J Opatowsky; Cedric W Spak; Kennith F Layton
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-07

5.  Antibiotic treatment for invasive nonpregnancy-associated listeriosis and mortality: a retrospective cohort study.

Authors:  Yaakov Dickstein; Yonatan Oster; Orit Shimon; Lior Nesher; Dafna Yahav; Yonit Wiener-Well; Regev Cohen; Ronen Ben-Ami; Miriam Weinberger; Galia Rahav; Yasmin Maor; Michal Chowers; Ran Nir-Paz; Mical Paul
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-10       Impact factor: 3.267

Review 6.  Antimicrobial chemotherapy of human infection due to Listeria monocytogenes.

Authors:  E M Jones; A P MacGowan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

7.  Effects of erythromycin in combination with penicillin, ampicillin, or gentamicin on the growth of Listeria monocytogenes.

Authors:  R L Penn; T T Ward; R T Steigbigel
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

8.  Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.

Authors:  G M Eliopoulos; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

9.  In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes.

Authors:  D L Winslow; G A Pankey
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

10.  AZDAST the new horizon in antimicrobial synergism detection.

Authors:  Navid Ziaei-Darounkalaei; Mehrdad Ameri; Taghi Zahraei-Salehi; Omid Ziaei-Darounkalaei; Tahereh Mohajer-Tabrizi; Lotfollah Bornaei
Journal:  MethodsX       Date:  2016-01-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.